BTEC - Principal Healthcare Innovators Index ETF
| Assets | $165.01M |
| NAV | $56.90 |
| Expense Ratio | 0.42% |
| PE Ratio | 12.75 |
| Beta (5Y) | 1.24 |
| Dividend (ttm) | $0.22 |
| Dividend Yield | 0.38% |
| Ex-Dividend Date | Dec 17, 2020 |
| 1-Year Return | - |
| Trading Day | April 21 |
| Last Price | $58.62 |
| Previous Close | $56.98 |
| Change ($) | 1.64 |
| Change (%) | 2.88% |
| Day's Open | 56.80 |
| Day's Range | 57.58 - 58.62 |
| Day's Volume | 7,514 |
| 52-Week Range | 36.23 - 73.38 |
Fund Description
The investment seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq Healthcare Innovators Index (the index). Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies that compose the index at the time of purchase. The index uses a quantitative model designed to identify equity securities in the Nasdaq US Benchmark Index that are small and medium capitalization U.S. healthcare companies.
| Asset Class Equity | Sector Large Cap |
| Region North America | Inception Date Aug 19, 2016 |
| Exchange NASDAQ | Ticker Symbol BTEC |
| Index Tracked NASDAQ U.S. Healthcare Innovators Index | |
Top 10 Holdings
25.21% of assets| Name | Symbol | Weight |
|---|---|---|
| Moderna | MRNA | 4.82% |
| Zimmer Biomet | ZBH | 3.07% |
| Horizon Therapeutics | HZNP | 2.73% |
| Exact Sciences | EXAS | 2.69% |
| Alnylam Pharmaceuticals | ALNY | 2.23% |
| Guardant Health | GH | 2.06% |
| Teladoc Health | TDOC | 2.01% |
| Dentsply Sirona | XRAY | 1.90% |
| BioMarin Pharmaceutical | BMRN | 1.86% |
| Seagen | SGEN | 1.85% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Apr 1, 2021 | $0.00 | Apr 7, 2021 |
| Dec 17, 2020 | $0.215 | Dec 22, 2020 |
| Dec 15, 2017 | $0.0416 | Dec 20, 2017 |
The coronavirus pandemic altered the healthcare landscape and how and where people work. The Principal Healthcare Innovators Index ETF (BTEC) is an exchange traded fund at the epicenter of those themes.
When it comes to innovation, healthcare is a sector-level leader, especially when the Principal Healthcare Innovators Index ETF (BTEC) taps into that trend. BTEC seeks to provide investment results that...
Biotech ETFs are climbing Wednesday as the Food and Drug Administration's staff endorsed Johnson & Johnson's coronavirus vaccine for emergency use, a key step in offering a third vaccination to the U.S....
The Principal Healthcare Innovators Index ETF (BTEC) became quite the story among healthcare exchange traded funds last year. BTEC seeks to provide investment results that closely correspond, before exp...
While much of the stock market and associated index ETFs are bathed in red to start the new year, Moderna is rallying, as the biotech company is boosting its vaccine output to help the spiking infection...
The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.
ETF Trends CEO Tom Lydon spoke with Ed Nini, Global Head of Product Strategy for Principal Global Investors, about the tumultuous year that has been 2020 and what kinds of strategies have been put into ...
Bolstered by positioning that includes exposure to companies fighting the coronavirus pandemic, the Principal Healthcare Innovators Index ETF (BTEC) is a pleasant surprise among healthcare exchange trad...
The Principal Healthcare Innovators Index ETF (BTEC) is often viewed as an exchange traded fund with access to biotechnology stocks and companies working on coronavirus vaccines. That's true, but the fu...
With progress being made on the coronavirus vaccine front, the Principal Healthcare Innovators Index ETF (BTEC) is an example of a healthcare exchange traded fund getting into its groove. Fortunately, t...
The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.
The race to bringing a coronavirus vaccine to market is heating up. That spells opportunity for the Principal Healthcare Innovators Index ETF (BTEC).
With the latest quarterly results season well underway, let's take a look at 3 stocks to buy for earnings announcement returns. The post 3 Stocks To Buy For Earnings Announcement Returns appeared first ...
The Principal Healthcare Innovators Index ETF (BTEC) is among the healthcare exchange traded funds that have encountered some rough sledding of late due to pre-Election Day jitters. However market obser...
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is an example of an exchange traded fund that's been sensitive to coronavirus vaccine headlines. While there's a lot to like about the Princi...
After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing.
The S&P 500, the Dow Jones and the Nasdaq Composite have lost about 0.6%, 0.03% and 0.6%, respectively, past week.
Biotechnology mergers and acquisitions appear to be back in a big way with news that Gilead Sciences (NASDAQ: GILD) is acquiring Immunomedics (NASDAQ: IMMU) for $21 billion.
Among healthcare ETFs, the Principal Healthcare Innovators Index ETF (BTEC) is one of the names taking the category by storm this year. BTEC seeks to provide investment results that closely correspond, ...
As we take a closer look at the opportunities in the biotechnology industry, investors can focus on healthcare developments posed to support rapid growth through a targeted exchange traded fund investme...
Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is already on a scintillating pace this year and that upside could be extended as a wave of coronavirus vaccines hits the wires over the near...
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is among the cadre of healthcare ETFs that are soaring this year owing to the COVID-19 pandemic, but with Election Day drawing closer, invest...
With significant tailwinds by way of the coronavirus pandemic, the Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is a rising star among healthcare ETFs. Fortunately, the long-term outlook for...
Amid the coronavirus pandemic, some healthcare ETFs are coming off age and showing they have the right mix of innovation and growth to reward investors. That group includes the Principal Healthcare Inno...
It’s been an eventful first seven months of 2020 for healthcare ETFs. With innovation and the coronavirus fight at the forefront of the sector discussion, the Principal Healthcare Innovators Index ETF (...
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is one of this year’s most impressive stories among the up-and-coming industry ETFs and the race to develop a coronavirus vaccine is a prime ...
Stock futures rocketed higher and are continuing the uptrend in overnight trading on Tuesday after Moderna said its coronavirus vaccine generated antibodies in all patients in an early trial, creating o...
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) got a lift Monday and it was none other than Moderna pushing the already hot ETF to new highs. BTEC tracks the Nasdaq U.S.
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is proving to be one of the most impressive healthcare ETFs this year and BTEC’s emergence as leader in its category is rooted in sound funda...
As its name implies, the Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) offers investors an innovative approach to healthcare investing. Some of that innovation is borne out of doing things di...
The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) jumped 42% in the second quarter and with telemedicine booming in the healthcare arena, this innovative ETF could just be getting started. BT...
Obviously, the Coronavirus pandemic is a negative, but there are some positives emerging, including advancements of services and technologies that were growing prior to the outbreak. That includes healt...
The coronavirus is pushing telemedicine to the forefront of healthcare, but not all ETFs are adequately levered to this theme. The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC), does however,...
Moderna (MRNA) is one of the biggest stories in the biotechnology space this year because the company is one of the leading contenders to bring a coronavirus vaccine to market. To that point, Moderna st...
Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.
If there’s one benefit emerging from the coronavirus crisis, it’s that renewed emphasis is being placed on healthcare innovation, a theme accessible via the Principal Healthcare Innovators Index ETF (Na...
Something's been brewing in the health care sector, the second-largest group in the S&P 500.
The COVID-19 pandemic is altering how medicine is practiced.
Since the coronavirus outbreak, health care technology has come to the fore with various innovations to combat the virus.
Healthcare is often viewed as a defensive sector, but as the group evolves, so does that reputation. These days, the sector is home to plenty of disruption and innovation, traits that are accessible wit...
